Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A metastasizing, slow-growing malignant epithelial neoplasm that arises from the exocrine pancreas. It is characterized by the presence of cysts and is composed of glycogen-rich malignant epithelial cells which produce a watery fluid. Signs and symptoms include upper gastrointestinal bleeding, weight loss, jaundice, and abdominal pain.
Biomarker and diagnostic research for pancreatic serous cystadenocarcinoma has been reported in the published literature.
No clinical trials have been registered for pancreatic serous cystadenocarcinoma.
24 publications have been identified in PubMed for pancreatic serous cystadenocarcinoma. Research spans Diagnostic / Biomarker (29%), Case Report / Case Series (25%), and Review / Meta-Analysis (21%).
Research Type | Count | % of Total |
|---|---|---|
Testing and diagnosis research | 7 | 29% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 12:26 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies
6 |
25% |
Research summaries | 5 | 21% |
Laboratory research | 3 | 13% |
Disease patterns and progression | 3 | 13% |
Menon G (2026). [PMID: 28846358](https://pubmed.ncbi.nlm.nih.gov/28846358/). *Unknown Journal*. [Review / Meta-Analysis]
Tashiro Y (2026). [PMID: 40522384](https://pubmed.ncbi.nlm.nih.gov/40522384/). *Abdominal radiology (New York)*. [Diagnostic / Biomarker]
Krueger JC (2026). [PMID: 41621283](https://pubmed.ncbi.nlm.nih.gov/41621283/). *Journal of comparative pathology*. [Case Report / Case Series]
Wilhelm S (2026). [PMID: 41559940](https://pubmed.ncbi.nlm.nih.gov/41559940/). *The American surgeon*. [Review / Meta-Analysis]
Tan C (2026). [PMID: 42150789](https://pubmed.ncbi.nlm.nih.gov/42150789/). *J Clin Pathol*. [Review / Meta-Analysis]
Menon G (2026). [PMID: 32491364](https://pubmed.ncbi.nlm.nih.gov/32491364/). *Unknown Journal*. [Review / Meta-Analysis]
Stevens KJ (2026). [PMID: 31613505](https://pubmed.ncbi.nlm.nih.gov/31613505/). *Unknown Journal*. [Diagnostic / Biomarker]
Romanish M (2025). [PMID: 40638990](https://pubmed.ncbi.nlm.nih.gov/40638990/). *Annals of diagnostic pathology*. [Epidemiology / Natural History]
Pea A (2025). [PMID: 40371932](https://pubmed.ncbi.nlm.nih.gov/40371932/). *The Journal of pathology*. [Basic Science / Preclinical]
Malaspina L (2025). [PMID: 40558295](https://pubmed.ncbi.nlm.nih.gov/40558295/). *Current oncology (Toronto, Ont.)*. [Epidemiology / Natural History]